Rick,regarding your comment "Why isn't everyone including the institutions in CYGX = They don't know about it yet - their learning as time pasts and when they learn of CYGX's value you will see great improvement in PPS." The institutions don't look at anything less than a penny. CYGX has to reach the $1.00 or better and get listed on the NASDAQ, then you will see institutions looking at it. Per the last PR, the company president has already presented CYGX's products, company strategy and business plans. So, some of the big boys are aware of the company. With more news on the distribution of the company's products, and the PPS will take off. Hopefully, we get some of this news soon as skooby and chipped have implied. GYGX has so much potential with the anti-herpes product alone, and that in China and India. When word gets around that the product is effective, more people will buy the stock.